Your browser doesn't support javascript.
loading
Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker.
Hurwitz, Stephanie N; Lockhart, Brian; Önder, Özlem; Wu, Rui; Sethi, Shenon; Aypar, Umut; Siebert, Reiner; Dogan, Ahmet; Pillai, Vinodh; Elenitoba-Johnson, Kojo S J; Lim, Megan S.
Afiliação
  • Hurwitz SN; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lockhart B; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Önder Ö; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wu R; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Sethi S; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Aypar U; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Dogan A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pillai V; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Elenitoba-Johnson KSJ; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center,
  • Lim MS; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center,
Mod Pathol ; 36(7): 100170, 2023 07.
Article em En | MEDLINE | ID: mdl-36997001

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Linfoma Difuso de Grandes Células B / Linfoma de Burkitt / Proteogenômica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mod Pathol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Linfoma Difuso de Grandes Células B / Linfoma de Burkitt / Proteogenômica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mod Pathol Ano de publicação: 2023 Tipo de documento: Article